Starter (subQ)
Timing and details
Loading…
Also known as: NAD · NAD plus · Nicotinamide adenine dinucleotide · beta-NAD · NAD peptide · NAD 500 · NAD 1000
Updated 60 sources
How it is thought to work. NAD+ shuttles electrons in the reactions that turn food into ATP, and it is the fuel for sirtuins and PARPs, enzymes tied to DNA repair and aging. Levels are said to fall with age, which is the whole pitch, though a 2026 review questions that for whole blood. Injected NAD+ may be broken down to NMN or NR outside cells before it gets in. In the one IV kinetics study, blood levels did not rise for 2 hours, as if cleared as fast as it went in.
Loading…
Loading…
Loading…
Loading…
Loading…
Loading…
Loading…
Loading…
Loading…
Loading…
Loading…
Loading…
Loading…
Loading…
Loading…
Loading…
Loading…
Loading…
Doses shown are what sources report, labelled by origin. Not medical advice.
Full NAD+ dosage guideEvery titration step in syringe units, missed doses and how to mix.| Water | Strength | 25 mgdose, units | 50 mgdose, units | 100 mgdose, units |
|---|---|---|---|---|
| 500 mg vial | ||||
| 2.5 mLCompetitor guide | 200 mg/mL | 12.50.125 mL | 250.25 mL | 500.5 mL |
| 3 mLCompetitor guide | 166.667 mg/mL | 150.15 mL | 300.3 mL | 600.6 mL |
| 5 mLCompetitor guide | 100 mg/mL | 250.25 mL | 500.5 mL | 1001 mL |
| 750 mg vial | ||||
| 7.5 mLCompetitor guide | 100 mg/mL | 250.25 mL | 500.5 mL | 1001 mL |
| 1,000 mg vial | ||||
| 3 mLCompetitor guide | 333.333 mg/mL | 7.50.075 mL | 150.15 mL | 300.3 mL |
| 5 mLCompetitor guide | 200 mg/mL | 12.50.125 mL | 250.25 mL | 500.5 mL |
| 10 mLCompetitor guide | 100 mg/mL | 250.25 mL | 500.5 mL | 1001 mL |
Doses shown are what sources report, labelled by origin. Not medical advice.
Calculate with this peptideYour vial, your water, your dose: NAD+ in syringe units, with the math shown.Community-reportedFrom 900 Reddit posts and comments, last mined Oct 23, 2026r/Biohackers, r/Peptidesource, r/Peptides, r/PeptideDiscussion
Goal not stated228 mentions
| Reported | Mentions |
|---|---|
| 100 mg | 55 |
| 50 mg | 42 |
| 25 mg | 32 |
| 500 mg | 20 |
| 1,000 mg | 17 |
Longevity and energy50 mentions
| Reported | Mentions |
|---|---|
| 100 mg | 17 |
| 50 mg | 12 |
| 25 mg | 10 |
| 20 mg | 4 |
| 75 mg | 3 |
Focus and mood9 mentions
| Reported | Mentions |
|---|---|
| 10 mg | 2 |
Left out: 23 mentions given in syringe units, which mean different doses in different mixes; 2 mentions far outside every sourced protocol, most likely vial sizes or typos.
| Reported | Mentions |
|---|---|
| Three times a week | 67 |
| Once a day | 44 |
| Twice a week | 36 |
| Every other day | 22 |
| 5 days on, 2 off | 12 |
Fatigue19 mentions
Most common fixes: stop taking it (4), lower the dose (3)
Flushing13 mentions
Most common fix: none (2)
Nausea9 mentions
Headache7 mentions
Most common fix: none (3)
Anxiety7 mentions
Burning sensation6 mentions
Most common fix: stop taking it (2)
Doses shown are what sources report, labelled by origin. Not medical advice.
From clinical trials and regulatory documents.
All 6 NAD+ IV clients in one 2026 study had moderate to severe symptoms that ended with the infusion. A review notes no study gives rates
How people manage it
Grant 2019 saw small, not clinically significant shifts (bilirubin up; AST, GGT and LD down). A 2024 preprint saw white cells and neutrophils rise after NAD+ IV
FDA reports consistent with endotoxin; one 2026 warning letter describes 3 ER visits after a lot tested at 3,360 EU/mL
How people manage it
From community reports and dosing guides. Not measured rates.
Commonly reported on r/Peptides; 64 injection-site irritation reports in one app's user logs
How people manage it
Expected by guides; redness fades in an hour or two, the lump in a day or two
How people manage it
Several users in one r/Peptides thread describe it; it passed in about 2 to 5 minutes
How people manage it
Reported on r/Peptides, even with a 7 am dose for some
How people manage it
Reported after a first shot on r/Peptides; 66 headache reports in one app's user logs
64 nausea reports in one app's user logs
Food-grade NAD+ in injectionsSubstance
FDA warned that food-grade NAD+ is not suitable for sterile compounding after reports of severe chills, shaking and vomiting consistent with endotoxin.
Dry, dark place. Room temperature is fine short term, 2 to 8 C for the long haul; one guide says -20 C. Guides disagree, and one even contradicts itself.
Fridge at 2 to 8 C, out of light, never frozen. About 4 weeks is the usual window, though guides range from 7 to 30 days and no stability data exists. Throw it out if it turns yellow or brown, cloudy or has particles. Crystals in the fridge usually mean the mix is too strong.
Pharmacy premixed vials (100 or 200 mg/mL) keep about 90 days from compounding in the fridge; discard 28 days after the first puncture.
Mixed with: Bacteriostatic water
Mixing. The most repeated mix is 500 mg with 5 mL, which makes 100 mg/mL so 1 unit on a U-100 syringe is 1 mg. Posters use 3 to 5 mL for 500 mg and say more water stings less. Strong mixes crystallize in the fridge: one user got crystals at 200 mg/mL, and replies blame anything above about 250 mg/mL when cold. Use more water.
Both are pitched for mitochondria and energy. No mechanistic conflict, but no human study of the pair. Posters run NAD+ 50 mg a day with MOTS-c 1 to 2 mg a day, and flushing questions come up.
One guide pairs SS-31 5 mg daily with NAD+ 100 mg subQ daily, mornings, for 8 to 12 weeks, then 4 weeks off. A poster ran SS-31 5 mg daily with NAD+ 100 mg every other day. The SS-31, MOTS-c and NAD+ trio is a frequent r/Peptides topic.
Listed as stackable with NAD+ by r/Peptides users. It is an NNMT inhibitor. We found no sourced explanation of how it would spare NAD+.
Methyl donors (TMG, folate, methylcobalamin) are suggested above 500 mg a day of precursor intake or with high homocysteine. Some posters blame methyl group depletion for bad reactions.
Grouped with NAD+ in longevity stacks by one guide.
Grouped with NAD+ for cognition by one guide.
Human evidence is sparse and mostly small, uncontrolled IV studies. Grant 2019 (11 men, 750 mg over 6 hours) saw plasma NAD+ rise 398% and urinary NAD+ 538% by 6 hours. Two small studies found NAD+ IV harder to tolerate than NR IV. No published human subQ data exists. Registered trials: NCT06919328 (NAD+ vs NR injections, 70 planned) and NCT07251608 (NR only). Precursors NMN and NR have the randomized trial data. On r/longevity, a shared review of 113 studies found no eligible outcome trials of IV or IM NAD+.
On FDA's list of bulk substances under evaluation for compounding.
Not FDA approved as an injectable drug. NAD is in Category 1 (under evaluation) on FDA's 503A list updated May 14, 2026, so 503A pharmacies can compound it. It is not on the 503B bulks list.
A disodium salt trihydrate form sits in 503A Category 3. In 2024 FDA warned compounders against food-grade NAD+ in sterile products after reactions consistent with endotoxin. FDA declared oral NMN lawful in supplements on September 29, 2025. WADA does not name NAD+ that we found, but IV infusions over 100 mL per 12 hours are a prohibited method outside hospital care, which catches most NAD+ drips.
WADA: Not confirmed
Most guides say 5 mL. That makes 100 mg/mL, so 1 unit on a U-100 insulin syringe is 1 mg and a 50 mg dose is 50 units. Some guides use 3 mL, which makes about 167 mg/mL and gets close to the strength where crystals become a problem in the fridge. Use the calculator for any other mix.
Most home subQ use sits at 25 to 100 mg a shot. Guides start around 25 mg twice a week, and 50 mg 3 times a week is where most home plans land. Raise about 25 mg at a time if it goes well. No human study has set a subQ dose, so all of this is convention.
Two to three times a week is the norm. Some guides go daily, at 100 to 250 mg, and one guide runs a 16-week daily ramp. Weekly totals across guides range from 50 mg to 1,750 mg, which shows how loose the convention is.
NAD+ is acidic, and a fast push makes it worse. Posters on r/Peptides fix it by adding more water and pushing slower. Buffered NAD+ is said to mix near pH 7 to 8.5 instead of 3 to 4, which stings less.
Several r/Peptides users describe sudden whole-body cramping a few minutes after pushing NAD+ fast, gone within about 2 to 5 minutes. The usual fix is a much slower push: inject a little, wait a minute or two, then finish over several minutes. After a bad one, posters restart at 15 to 25 mg.
It is too concentrated for the cold. One user put 5 mL in a 1,000 mg vial (200 mg/mL) and got crystals. Replies point at anything above about 250 mg/mL when chilled and say to use more water.
Morning. NAD+ keeps a lot of people awake when taken later, and a few report it even with a 7 am dose. Guides say the same.
Users on r/Peptides lean toward injection. Nasal sprays deliver about 5 mg per spray, so even a 20 mg day is small next to a 50 to 100 mg shot. No human study has measured blood NAD+ after a nasal dose.
Compounding pharmacies make them at 300 mg/mL in a 15 mL bottle. Research sprays run weaker, for example 500 mg in 10 mL (50 mg/mL), about 5 mg per 0.1 mL spray. Check the label before you count sprays.
No. It is a coenzyme every cell uses to make energy and run repair enzymes like sirtuins and PARPs. It sits next to peptides because it is sold the same way: powder in a vial, mixed with bacteriostatic water, drawn with an insulin syringe.
Users on r/Peptides say no. We found no data either way.
One guide says 2 to 4 weeks for subQ. Another says hours to a day after an IV session.
About 4 weeks in the fridge by convention. Guides range from 7 to 30 days, and none has stability data. Toss it if it turns yellow or brown, cloudy or grainy.
IV is 250 to 1,000 mg over 1 to 4 or more hours in a clinic, at roughly $300 to $1,000 a session. SubQ is 25 to 100 mg at home, at about $2 to $8 per 100 mg. No human study has compared them head to head. A registered trial is now set up to test IM, subQ and IV push.
Pharmacy guidance starts around 20 mg and works up toward 100 mg, and puts about 300 mg a week subQ as the ceiling without further evaluation. One competitor guide uses the same 300 mg figure.
The small studies so far favor NR. In Reyna 2026, NR went in over 37 minutes against 97 for NAD+, and every NAD+ client had moderate to severe symptoms during the drip. In a 2024 preprint, NR IV raised blood NAD+ 20.7% at 3 hours and beat NAD+ IV, which also caused more and stronger infusion reactions.
No. FDA has received reports of severe chills, shaking, vomiting and fatigue after NAD+ injectables that fit endotoxin contamination, and warned compounders off food-grade NAD+. A January 2026 warning letter describes 3 people sent to the ER with low blood pressure and shaking after one lot. Normal NAD+ effects are sting, cramping on a fast push and restlessness.
No injectable NAD+ product is FDA approved. NAD sits in Category 1 (under evaluation) on FDA's 503A list updated May 14, 2026, so 503A pharmacies can compound it under the interim policy. It is not on the 503B bulks list. Oral NMN was declared lawful in supplements in September 2025.
We found no listing of NAD+ itself. The catch is the drip: IV infusions over 100 mL per 12 hours are a prohibited method outside hospital care, surgery or diagnostics, and a typical NAD+ drip is 250 to 500 mL.
It is debated. A 2026 review calls human evidence sparse and says healthy aging may not lower whole-blood NAD+. That cuts against the core pitch for topping it up.
Nobody has measured it for injected NAD+. Some guides print about 45 minutes for IV, others just say minutes, and neither cites a source. In the one IV kinetics study, blood levels stayed flat for 2 hours while it went in, then climbed.
Answers come from this site's pages only, with a link to each source.
60 sources, each checked by date. Record updated Oct 23, 2026. Numbers are restated in our own words and labelled by where they came from.